National Bankshares set a C$15.40 target price on Extendicare (TSE:EXE - Free Report) in a report published on Thursday morning,BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.
EXE has been the topic of several other research reports. BMO Capital Markets raised their price objective on shares of Extendicare from C$13.50 to C$14.50 in a research report on Monday, May 12th. TD Securities lifted their target price on shares of Extendicare from C$13.00 to C$15.00 and gave the stock a "hold" rating in a research report on Thursday, May 22nd. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of C$13.98.
Check Out Our Latest Research Report on EXE
Extendicare Price Performance
TSE:EXE traded up C$0.01 during trading hours on Thursday, hitting C$12.92. The stock had a trading volume of 88,323 shares, compared to its average volume of 184,341. The company has a 50 day simple moving average of C$14.03 and a two-hundred day simple moving average of C$12.80. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The firm has a market capitalization of C$1.08 billion, a price-to-earnings ratio of 16.47 and a beta of 1.26. Extendicare has a one year low of C$7.34 and a one year high of C$15.24.
Extendicare Dividend Announcement
The business also recently declared a jul 25 dividend, which will be paid on Friday, August 15th. Investors of record on Thursday, July 31st will be given a dividend of $0.042 per share. This represents a dividend yield of 3.81%. The ex-dividend date is Thursday, July 31st. Extendicare's dividend payout ratio is currently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
